The data will be reported as a poster presentation at the 29th Annual Congress of the World Muscle Society, which will be ...
Featured data includes presentations detailing the long-term efficacy of atidarsagene autotemcel, formerly OTL-200, which was approved in March 2024 as Lenmeldyâ„¢ in the United States and is ...